LSC Webinars CELL All

31. Breaking Barriers With PCR: Innovative Solutions For Clinical Trial Success 9/3/2025

    This presentation brings together experts from Precision for Medicine, Avidity Biosciences, and Indaptus Therapeutics to examine the expanding role of PCR-based molecular monitoring.

32. Cell Cycle Mapping In Tumors With Advanced Technologies 9/2/2025

    Discover how spatial profiling and advanced imaging tools are transforming drug discovery, featuring Wayne Stallaert’s lab’s work on cell cycle mapping and biomarker insights in cancer research.

33. Scaling Plasmid DNA Production: A Proven Strategy For Higher Yields 8/27/2025

    Learn how an agile manufacturing partner scaled their plasmid DNA production and achieved higher yields by optimizing their media selection and fermentation processes.

34. Unlock Viral Vector Yield And Efficiency With Upstream Intensification 8/26/2025

    Streamline viral vector manufacturing with perfusion technologies that reduce costs and improve scalability. Discover how a tangential flow depth filtration system enhances yield and quality.

35. Enabling CTA Submission In Record Time: Adenovirus Program Success 8/25/2025

    What does it take to bring an adenovirus-based therapy to the clinic – faster and without compromising quality? Find actionable insights to help improve efficiency and accelerate development timelines.

36. Donor-To-Dose Solutions For Scalable Cell Therapy Manufacturing 8/21/2025

    From enabling earlier insights through donor characterization to reducing manufacturing variability through cell separation technologies, explore real-world case studies and actionable approaches to scale smarter.

37. Next-Gen Disease Models And Cell Therapeutics: Innovations In AI, Omics And Collaboration 8/20/2025

    Learn how to leverage AI, omics integration, and collaborative research to build more physiologically relevant disease models and accelerate the development of next-gen cell therapies.

38. Efficient Scale-Up Of Monoclonal Antibody Production: From Bench Top To 500L 8/11/2025

    Scaling monoclonal antibody production from the lab to a commercial scale can be challenging. Learn about an approach that helps you maintain consistent productivity and product quality across all scales.

39. A Case Study For Viral Vector Process Impurity Profile: Evaluation Of EndoCleave 8/11/2025

    Endonucleases are essential for clearing DNA impurities in viral vector manufacturing. Learn how a new enzyme compares to other commercially available options in AAV and LVV production.

40. Accelerating CGT Scale-Up With An Advanced Manufacturing Platform 8/6/2025

    By exploring the integration of advanced manufacturing platforms, you can discover how to improve biological performance and leverage the economic and operational benefits of closed systems.